Immunovant

$Immunovant(IMVT)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-009448  Act: 33  Size: 6 KB 网页链接

$Immunovant(IMVT)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-316765  Act: 33  Size: 628 KB 网页链接

$Immunovant(IMVT)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-25-314722  Act: 34  Size: 43 KB 网页链接

$Immunovant(IMVT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-317577  Act: 34  Size: 421 KB 网页链接

$Immunovant(IMVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-045409  Size: 5 KB 网页链接

$Immunovant(IMVT)$ 8-K Current report, item 5.02 Accession Number: 0001764013-25-000153  Act: 34  Size: 140 KB 网页链接

$Immunovant(IMVT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001764013-26-000011  Act: 34  Size: 5 MB 网页链接

$Immunovant(IMVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001764013-25-000156  Size: 15 KB 网页链接

$Immunovant(IMVT)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-009563  Act: 33  Size: 4 KB 网页链接

$Immunovant(IMVT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001764013-25-000148  Act: 34  Size: 285 KB 网页链接

$Immunovant(IMVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001764013-25-000163  Size: 56 KB 网页链接

$Immunovant(IMVT)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001140361-25-045411  Act: 34  Size: 10 KB 网页链接

$Immunovant(IMVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001764013-25-000159  Size: 15 KB 网页链接

$Immunovant(IMVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001764013-26-000002  Size: 7 KB 网页链接

$Immunovant(IMVT)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-009565  Act: 33  Size: 5 KB 网页链接

$Immunovant(IMVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001764013-25-000160  Size: 15 KB 网页链接

$Immunovant(IMVT)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-009391  Act: 33  Size: 6 KB 网页链接

$Immunovant(IMVT)$ 8-K Current report, item 8.01 Accession Number: 0001193125-25-314994  Act: 34  Size: 165 KB 网页链接

$Immunovant(IMVT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001764013-25-000149  Act: 34  Size: 4 MB 网页链接

$Immunovant(IMVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001702969-26-000002  Size: 5 KB 网页链接